Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail
  • Print
  • Share
  • E-mail
-
 
Pediatric Labeling Date:  03/06/2014
 
Trade Name:  Revatio
 
Generic Name or Proper Name (*):  sildenafil
 
Indications Studied:  Treatment of pulmonary arterial hypertension (PAH)
 
Label Changes Summary:  Labeling updated to include information on results of an open-label pediatric safety extension studyDuring the study, there were 42 deaths with 37 of these deaths reported prior to a decision to titrate patients to a lower dosage because of a finding of increased mortality. An increase in mortality was observed with increasing doses Causes of death in the extension study were typical of patients with PAH
 
Product Labeling:  Labeling  Opens a new window
 
BPCA(B):  B
 
Sponsor:  Pfizer
 
Pediatric Exclusivity Granted Date:  02/09/2012
 
NNPS:  FALSE'
 
Therapeutic Category:  Peripheral vasodilator
 
-
-